Back to top

medical-devices: Archive

Indrajit Bandyopadhyay

ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue

Intuitive Surgical's growth rests on da Vinci 5, Ion, SP and digital tools as recurring revenue rises and procedure risks persist.

ISRGPositive Net Change JNJPositive Net Change MDTNegative Net Change

Indrajit Bandyopadhyay

Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise

ISRG's strong procedure growth, recurring revenue and cash position support its case, but tariffs, mix shifts and placement risks cloud the outlook.

ISRGPositive Net Change JNJPositive Net Change MDTNegative Net Change

Zacks Equity Research

Revvity to Launch Signals for Startups for Emerging Biotech Companies

RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.

RVTYNegative Net Change ISRGPositive Net Change CAHPositive Net Change WSTPositive Net Change

Indrajit Bandyopadhyay

ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure

ISRG's growth is fueled by robotic surgery, Ion lung biopsy and AI tools, while tariffs, product mix and softer demand pressure margins.

ISRGPositive Net Change JNJPositive Net Change MDTNegative Net Change

Zacks Equity Research

Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth?

Intuitive Surgical's valuation has eased as U.S. procedure growth slows, but margin gains, AI software expansion and global growth could support its premium.

ISRGPositive Net Change IDXXPositive Net Change GKOSNegative Net Change

Zacks Equity Research

Labcorp Prepares to Report Q2 Earnings: What's in the Cards?

LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.

LHNegative Net Change HSICPositive Net Change ALCNegative Net Change CVSNegative Net Change

Benjamin Rains

The Best "Strong Buy" Stocks to Buy as Q2 Earnings Season Heats Up

Finding the best Zacks Rank #1 (Strong Buy) stocks out of a group of over 200 highly-ranked stocks to consider buying as Q2 earnings season ramps up.

BWAYNegative Net Change

Zacks Equity Research

GEHC Launches MIM Anyware for Secure Remote Imaging Collaboration

GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.

GEHCNegative Net Change ISRGPositive Net Change CAHPositive Net Change WSTPositive Net Change